
Phase II study of epirubicin plus oxaliplatin and infusional 5-fluorouracil as first-line combination therapy in patients with metastatic or advanced gastric cancer
Zhang, Chen X., Huang, Sui, Xu, Nong, Fang, Jia W., Shen, Peng, Bao, Yin H., Mou, Bo H., Shi, Ming G., Zhong, Xing L., Xiong, Ping J.Volume:
18
Langue:
english
Journal:
Anti-Cancer Drugs
DOI:
10.1097/cad.0b013e3280146296
Date:
June, 2007
Fichier:
PDF, 89 KB
english, 2007